Description

Book Synopsis


Table of Contents

Acknowledgments ix

Introduction x

Chapter 1 The $1000 Pill: the Fiscal Consequences of Curing Hepatitis C 1

Chapter 2 Enter the Payers: Fda Approval Does Not Guarantee Commercial Success 10

Chapter 3 Pandemic: mRNA Vaccines And The Race For A Cure 19

Chapter 4 Federal Investment in R&d: Why the Government Does Not Deserve a Piece of Biopharma’s Profits? 34

Chapter 5 Insulin: the True Cost of a 100- Year- Old Drug 44

Chapter 6 The Costly Alzheimer’s Disease Drug: a Questionable Breakthrough 50

Chapter 7 Gene Therapy: How Much Is a Life Worth? 60

Chapter 8 Proving the Value of Expensive Drugs: Should We Pay For Drugs Whose Ultimate Value Is Unknown? 70

Chapter 9 Generic Drugs: Built- in Cost Controls 74

Chapter 10 About Those Soaring Pharma Profits: Are They Driving Healthcare Costs? 80

Chapter 11 Schemes to Lower Drug Prices: the Impact of Reduced Resources on R&d 84

Final Thoughts 96

Index 98

Pharma and Profits

    Product form

    A Paperback / softback by John L. LaMattina

    £19.51

    Includes FREE delivery

    RRP £22.95 – you save £3.44 (14%)

    Order before 4pm on Wednesday for delivery by Fri 27 Nov 2026.

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Pharma and Profits by John L. LaMattina

      Book details

      Publisher John Wiley & Sons Inc
      Published 23 September 2022
      ISBN-13 9781119881339
      978-1119881339
      ISBN-10 1119881331
      Also in:
      Pre-clinical medicine: basic sciences Chemistry Medicinal chemistry

      Description

      Book Synopsis


      Table of Contents

      Acknowledgments ix

      Introduction x

      Chapter 1 The $1000 Pill: the Fiscal Consequences of Curing Hepatitis C 1

      Chapter 2 Enter the Payers: Fda Approval Does Not Guarantee Commercial Success 10

      Chapter 3 Pandemic: mRNA Vaccines And The Race For A Cure 19

      Chapter 4 Federal Investment in R&d: Why the Government Does Not Deserve a Piece of Biopharma’s Profits? 34

      Chapter 5 Insulin: the True Cost of a 100- Year- Old Drug 44

      Chapter 6 The Costly Alzheimer’s Disease Drug: a Questionable Breakthrough 50

      Chapter 7 Gene Therapy: How Much Is a Life Worth? 60

      Chapter 8 Proving the Value of Expensive Drugs: Should We Pay For Drugs Whose Ultimate Value Is Unknown? 70

      Chapter 9 Generic Drugs: Built- in Cost Controls 74

      Chapter 10 About Those Soaring Pharma Profits: Are They Driving Healthcare Costs? 80

      Chapter 11 Schemes to Lower Drug Prices: the Impact of Reduced Resources on R&d 84

      Final Thoughts 96

      Index 98

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account